Insider Trading › SRRK › Insiders

Scholar Rock Holding Corp

SRRK·Nasdaq·United States United States·Insider activity
$48.13
-2.24 (-4.45%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
SRRK
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SRRKS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

In the last 180 days, SRRK insiders filed 6 purchases ($12.0M) and 13 sales ($923K) on the open market, by 6 insiders. Newest filing Oct 27, 2026 (25 days ago).

Net Insider Buying by Quarter

Shares bought (+) or sold (−) on the open market by SRRK insiders · Form 4 · last two years
-500.0K-250.0K0250.0K500.0K2025 Q1: -340.4K2025 Q12025 Q2: -89.9K2025 Q22025 Q3: -44.9K2025 Q32025 Q4: 392.6K2025 Q42026 Q1: -207.5K2026 Q12026 Q2: -63.5K2026 Q22026 Q3: -17.1K2026 Q32026 Q4: 289.5K2026 Q4

On Record

$12.0MPurchases · 180 days
$923KSales · 180 days
193Open-market transactions on record
6Insiders filing · 180 days

Purchases (code P) and sales (code S) of SRRK common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).

Insider Transactions

193 on record · newest trade first
AllPurchasesSalesOfficers & directors
InsiderTypeSharesPriceValueHeld afterTradedFiled
AKKARAJU SRINIVASDirector · Director Purchase +98.0K $41.59 $4.1M723.0Kindirect Oct 26, 2026Oct 27, 2026 Form 4 ↗
AKKARAJU SRINIVASDirector · Director Purchase +49.0K $41.59 $2.0M6.4Mindirect Oct 26, 2026Oct 27, 2026 Form 4 ↗
AKKARAJU SRINIVASDirector · Director Purchase +94.0K $41.31 $3.9M624.0Kindirect Oct 23, 2026Oct 27, 2026 Form 4 ↗
AKKARAJU SRINIVASDirector · Director Purchase +500 $41.82 $21K6.3Mindirect Oct 23, 2026Oct 27, 2026 Form 4 ↗
AKKARAJU SRINIVASDirector · Director Purchase +47.0K $41.31 $1.9M6.3Mindirect Oct 23, 2026Oct 27, 2026 Form 4 ↗
AKKARAJU SRINIVASDirector · Director Purchase +1,000 $41.82 $42K625.0Kindirect Oct 23, 2026Oct 27, 2026 Form 4 ↗
FLIER JEFFREY S.Director Sale −15 $54.88 $82327.9Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
FLIER JEFFREY S.Director Sale −1,470 $54.24 $80K27.9Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
FLIER JEFFREY S.Director Sale −1,568 $53.53 $84K29.3Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Gilman MichaelDirector Sale −43 $54.81 $2K59.5Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Gilman MichaelDirector Sale −1,155 $54.23 $63K59.6Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Gilman MichaelDirector Sale −1,346 $53.54 $72K60.7Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Burow KristinaDirector Sale −948 $54.28 $51K114.7Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Burow KristinaDirector Sale −2,105 $53.49 $113K115.6Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Reed JoshuaDirector Sale −948 $54.28 $51K19.5Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Reed JoshuaDirector Sale −2,105 $53.50 $113K20.5Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Peng KatieDirector Sale −21 $54.96 $1K34.3Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Peng KatieDirector Sale −2,437 $54.25 $132K34.3Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Peng KatieDirector Sale −2,988 $53.56 $160K36.8Kdirect Jul 1, 2026Jul 6, 2026 Form 4 ↗
Woods KeithChief Operating Officer Sale −10.2K $49.57 $507K620.1Kdirect Apr 16, 2026Apr 20, 2026 Form 4 ↗
Vaishnaw AkshayPresident of R&D · Director Sale −12.2K $49.57 $607K630.5Kdirect Apr 16, 2026Apr 20, 2026 Form 4 ↗
Sinha VikasChief Financial Officer Sale −10.4K $49.57 $516K619.9Kdirect Apr 16, 2026Apr 20, 2026 Form 4 ↗
Hallal DavidChief Executive Officer · Director Sale −30.6K $49.57 $1.5M1.6Mdirect Apr 16, 2026Apr 20, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −200 $48.48 $10K98.4Kdirect Feb 23, 2026Feb 25, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −857 $47.86 $41K98.6Kdirect Feb 23, 2026Feb 25, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −7,427 $46.94 $349K99.5Kdirect Feb 23, 2026Feb 25, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −7,989 $46.53 $372K106.9Kdirect Feb 17, 2026Feb 19, 2026 Form 4 ↗
Parlavecchio CarynCHRO Sale −9,035 $46.53 $420K169.1Kdirect Feb 17, 2026Feb 19, 2026 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −9,580 $46.53 $446K241.5Kdirect Feb 17, 2026Feb 19, 2026 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −4,157 $46.53 $193K126.0Kdirect Feb 17, 2026Feb 19, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −12.8K $46.85 $599K85.7Kdirect Jan 22, 2026Jan 23, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −2,119 $45.87 $97K98.4Kdirect Jan 22, 2026Jan 23, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −8,406 $44.48 $374K100.6Kdirect Jan 16, 2026Jan 21, 2026 Form 4 ↗
Parlavecchio CarynCHRO Sale −6,600 $44.48 $294K148.9Kdirect Jan 16, 2026Jan 21, 2026 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −8,016 $44.48 $357K214.6Kdirect Jan 16, 2026Jan 21, 2026 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −5,798 $44.48 $258K95.7Kdirect Jan 16, 2026Jan 21, 2026 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −13.1K $45.20 $593K109.0Kdirect Jan 14, 2026Jan 16, 2026 Form 4 ↗
Sinha VikasChief Financial Officer Sale −16.8K $42.70 $715K583.2Kdirect Jan 13, 2026Jan 15, 2026 Form 4 ↗
Woods KeithChief Operating Officer Sale −16.7K $42.70 $715K583.3Kdirect Jan 13, 2026Jan 15, 2026 Form 4 ↗
Vaishnaw AkshayPresident of R&D · Director Sale −20.4K $42.70 $873K595.8Kdirect Jan 13, 2026Jan 15, 2026 Form 4 ↗
Hallal DavidChief Executive Officer · Director Sale −57.5K $42.70 $2.5M1.5Mdirect Jan 13, 2026Jan 15, 2026 Form 4 ↗
Peng KatieDirector Sale −280 $44.63 $12K32.9Kdirect Dec 16, 2025Dec 18, 2025 Form 4 ↗
Peng KatieDirector Sale −726 $43.88 $32K33.2Kdirect Dec 16, 2025Dec 18, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −136.5K $45.21 $6.2M109.0Kdirect Dec 4, 2025Dec 5, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +4,403 $40.97 $180K530.0Kindirect Oct 7, 2025Dec 16, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +12.4K $40.18 $498K525.6Kindirect Oct 7, 2025Dec 16, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +12.8K $39.31 $503K513.2Kindirect Oct 7, 2025Dec 16, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +13.7K $39.52 $543K500.4Kindirect Oct 6, 2025Oct 7, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +80.9K $38.68 $3.1M486.7Kindirect Oct 6, 2025Oct 7, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +18.4K $37.89 $698K405.8Kindirect Oct 6, 2025Oct 7, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +319.7K $37.42 $12.0M387.4Kindirect Oct 3, 2025Oct 7, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +56.7K $36.74 $2.1M67.7Kindirect Oct 3, 2025Oct 7, 2025 Form 4 ↗
AKKARAJU SRINIVASDirector Purchase +11.0K $35.61 $392K11.0Kindirect Oct 3, 2025Oct 7, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −3,353 $30.67 $103K109.0Kdirect Sep 22, 2025Sep 24, 2025 Form 4 ↗
Peng KatieDirector Sale −76 $33.20 $3K33.9Kdirect Sep 16, 2025Sep 17, 2025 Form 4 ↗
Peng KatieDirector Sale −930 $32.48 $30K34.0Kdirect Sep 16, 2025Sep 17, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −3,178 $33.52 $107K112.3Kdirect Sep 16, 2025Sep 17, 2025 Form 4 ↗
Parlavecchio CarynCHRO Sale −2,178 $31.17 $68K155.5Kdirect Aug 18, 2025Aug 19, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −11.1K $40.02 $446K0indirect Jul 16, 2025Jul 18, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −24.1K $34.44 $829K115.5Kdirect Jul 8, 2025Jul 10, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −11.1K $33.21 $370K11.1Kindirect Jun 23, 2025Jun 25, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −2,766 $32.74 $91K24.1Kdirect Jun 23, 2025Jun 25, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −17.6K $32.16 $564K26.8Kdirect Jun 23, 2025Jun 25, 2025 Form 4 ↗
Peng KatieDirector Sale −54 $32.53 $2K34.9Kdirect Jun 16, 2025Jun 17, 2025 Form 4 ↗
Peng KatieDirector Sale −2,977 $31.96 $95K35.0Kdirect Jun 16, 2025Jun 17, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −3,668 $32.00 $117K139.6Kdirect Jun 16, 2025Jun 17, 2025 Form 4 ↗
Parlavecchio CarynCHRO Sale −6,186 $32.00 $198K157.6Kdirect Jun 16, 2025Jun 17, 2025 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −7,442 $32.00 $238K222.6Kdirect Jun 16, 2025Jun 17, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −4,975 $29.84 $148K24.1Kdirect May 29, 2025May 30, 2025 Form 4 ↗
FLIER JEFFREY S.Director Sale −1,100 $29.23 $32K29.0Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Burow KristinaDirector Sale −4,400 $29.83 $131K21.1Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Burow KristinaDirector Sale −1,000 $29.24 $29K25.5Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Gilman MichaelDirector Sale −2,745 $29.83 $82K55.2Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Gilman MichaelDirector Sale −630 $29.22 $18K58.0Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Brudnick RichardDirector Sale −1,400 $30.00 $42K15.1Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Brudnick RichardDirector Sale −4,675 $29.63 $139K16.5Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Reed JoshuaDirector Sale −500 $30.04 $15K15.7Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Reed JoshuaDirector Sale −4,900 $29.68 $145K16.2Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Vaishnaw AkshayPresident of R&D · Director Sale −1,620 $30.01 $49K616.2Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Vaishnaw AkshayPresident of R&D · Director Sale −5,130 $29.63 $152K617.8Kdirect May 29, 2025May 30, 2025 Form 4 ↗
Sacco TraceyChief Commercial Officer Sale −84 $33.49 $3K71.8Kdirect Apr 25, 2025Apr 29, 2025 Form 4 ↗
Sacco TraceyChief Commercial Officer Sale −4,916 $32.81 $161K71.8Kdirect Apr 25, 2025Apr 29, 2025 Form 4 ↗
Sacco TraceyChief Commercial Officer Sale −5,000 $32.89 $164K71.8Kdirect Mar 24, 2025Mar 25, 2025 Form 4 ↗
Sacco TraceyChief Commercial Officer Sale −1,500 $33.70 $51K76.8Kdirect Mar 24, 2025Mar 25, 2025 Form 4 ↗
Moore ErinInterim PFO and PAO Sale −13.6K $33.12 $449K82.6Kdirect Mar 24, 2025Mar 25, 2025 Form 4 ↗
Peng KatieDirector Sale −1,006 $34.42 $35K30.3Kdirect Mar 17, 2025Mar 19, 2025 Form 4 ↗
Myles Edward HCOO & CFO Sale −29.4K $34.87 $1.0M111.3Kdirect Mar 10, 2025Mar 12, 2025 Form 4 ↗
Myles Edward HCOO & CFO Sale −112.9K $35.82 $4.0M140.7Kdirect Mar 10, 2025Mar 12, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −20.2K $37.74 $762K111.1Kdirect Feb 19, 2025Feb 20, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −8,341 $37.56 $313K131.3Kdirect Feb 19, 2025Feb 20, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −40.0K $37.20 $1.5M139.6Kdirect Feb 19, 2025Feb 20, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −4,135 $36.83 $152K131.3Kdirect Feb 18, 2025Feb 20, 2025 Form 4 ↗
Parlavecchio CarynCHRO Sale −5,296 $36.83 $195K140.3Kdirect Feb 18, 2025Feb 20, 2025 Form 4 ↗
Myles Edward HCOO & CFO Sale −7,809 $36.83 $288K140.7Kdirect Feb 18, 2025Feb 20, 2025 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −5,742 $36.83 $211K189.3Kdirect Feb 18, 2025Feb 20, 2025 Form 4 ↗
Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director Sale −18.4K $36.83 $677K312.0Kdirect Feb 18, 2025Feb 20, 2025 Form 4 ↗
Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director Sale −22.3K $44.20 $986K330.4Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −5,655 $44.20 $250K67.2Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Sacco TraceyChief Commercial Officer Sale −3,890 $44.20 $172K45.4Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −7,347 $44.20 $325K135.4Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Parlavecchio CarynCHRO Sale −6,434 $44.20 $284K145.6Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Myles Edward HCOO & CFO Sale −12.5K $44.20 $554K148.5Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −9,039 $44.20 $400K195.0Kdirect Jan 16, 2025Jan 21, 2025 Form 4 ↗
Invus Global Management, LLC10% owner Sale −1.6M $41.65 $66.6M9.3Mdirect Dec 10, 2024Dec 12, 2024 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Sale −149 $40.98 $6K10.9Mdirect Nov 25, 2024Nov 27, 2024 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Sale −30.7K $40.14 $1.2M10.9Mdirect Nov 25, 2024Nov 27, 2024 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Sale −126.4K $39.51 $5.0M10.9Mdirect Nov 25, 2024Nov 27, 2024 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Sale −43.9K $38.43 $1.7M11.0Mdirect Nov 25, 2024Nov 27, 2024 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Sale −208.3K $37.63 $7.8M11.1Mdirect Nov 25, 2024Nov 27, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −200 $40.72 $8K72.9Kdirect Nov 25, 2024Nov 26, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −3,075 $39.93 $123K73.1Kdirect Nov 25, 2024Nov 26, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −2,100 $39.25 $82K76.1Kdirect Nov 25, 2024Nov 26, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −1,000 $38.04 $38K78.2Kdirect Nov 25, 2024Nov 26, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −2,145 $30.01 $64K72.9Kdirect Nov 22, 2024Nov 26, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −2,105 $30.00 $63K72.9Kdirect Nov 11, 2024Nov 13, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −37.2K $34.90 $1.3M161.1Kdirect Oct 8, 2024Oct 10, 2024 Form 4 ↗
AKKARAJU SRINIVASDirector Sale −155.7K $32.50 $5.1M5.6Mindirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
AKKARAJU SRINIVASDirector Sale −510.0K $30.00 $15.3M5.8Mindirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
AKKARAJU SRINIVASDirector Sale −510.0K $27.50 $14.0M6.3Mindirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −31.3K $29.05 $908K161.1Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −25.8K $27.27 $704K192.3Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −37.2K $26.83 $998K218.2Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −112.0K $25.61 $2.9M255.4Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Sacco TraceyCHIEF COMMERCIAL OFFICER Sale −1,964 $26.23 $52K49.3Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Sacco TraceyCHIEF COMMERCIAL OFFICER Sale −28.0K $25.58 $717K51.2Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −39.4K $30.06 $1.2M72.9Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −2,552 $26.22 $67K112.2Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Marantz Jing L.CHIEF MEDICAL OFFICER Sale −67.4K $25.59 $1.7M114.8Kdirect Oct 7, 2024Oct 7, 2024 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −1,936 $8.58 $17K142.8Kdirect Sep 16, 2024Sep 19, 2024 Form 4 ↗
Parlavecchio CarynCHRO Sale −1,451 $9.33 $14K152.0Kdirect Aug 16, 2024Aug 19, 2024 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −2,315 $8.99 $21K144.7Kdirect Jun 17, 2024Jun 18, 2024 Form 4 ↗
Parlavecchio CarynCHRO Sale −4,305 $8.98 $39K153.4Kdirect Jun 17, 2024Jun 18, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −9,458 $8.98 $85K201.5Kdirect Jun 17, 2024Jun 18, 2024 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −4,695 $8.98 $42K204.1Kdirect Jun 17, 2024Jun 18, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −4,744 $15.74 $75K211.0Kdirect Feb 16, 2024Feb 21, 2024 Form 4 ↗
Qatanani MoCHIEF SCIENTIFIC OFFICER Sale −2,512 $15.74 $40K147.0Kdirect Feb 16, 2024Feb 20, 2024 Form 4 ↗
Parlavecchio CarynCHRO Sale −3,751 $15.74 $59K157.7Kdirect Feb 16, 2024Feb 20, 2024 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −3,489 $15.74 $55K208.8Kdirect Feb 16, 2024Feb 20, 2024 Form 4 ↗
Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director Sale −11.6K $15.74 $183K352.7Kdirect Feb 16, 2024Feb 20, 2024 Form 4 ↗
Qatanani MoSVP AND HEAD OF RESEARCH Sale −2,002 $15.93 $32K78.8Kdirect Jan 16, 2024Jan 18, 2024 Form 4 ↗
Parlavecchio CarynCHRO Sale −2,849 $15.93 $45K114.3Kdirect Jan 16, 2024Jan 18, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −6,634 $15.93 $106K162.2Kdirect Jan 16, 2024Jan 18, 2024 Form 4 ↗
Ho JunlinGENERAL COUNSEL Sale −4,186 $15.93 $67K154.4Kdirect Jan 16, 2024Jan 18, 2024 Form 4 ↗
Myles Edward HCOO & CFO Sale −300 $19.51 $6K168.8Kdirect Dec 29, 2023Dec 29, 2023 Form 4 ↗
Myles Edward HCOO & CFO Sale −12.2K $18.82 $229K169.1Kdirect Dec 29, 2023Dec 29, 2023 Form 4 ↗
Qatanani MoSVP AND HEAD OF RESEARCH Sale −24.7K $18.18 $448K80.8Kdirect Dec 14, 2023Dec 15, 2023 Form 4 ↗
Myles Edward HCOO & CFO Sale −24.9K $17.53 $437K168.8Kdirect Dec 7, 2023Dec 8, 2023 Form 4 ↗
Myles Edward HCOO & CFO Sale −35.0K $12.51 $438K168.8Kdirect Nov 2, 2023Nov 3, 2023 Form 4 ↗
AKKARAJU SRINIVASDirector · 10% owner Purchase +2.2M $6.85 $15.0M6.8Mindirect Oct 16, 2023Oct 18, 2023 Form 4 ↗
Samsara BioCapital GP, LLC10% owner Purchase +2.2M $6.85 $15.0M6.8Mindirect Oct 16, 2023Oct 18, 2023 Form 4 ↗
Wittouck Amaury10% owner Purchase +10.2K $8.55 $87K11.3Mdirect Oct 12, 2023Oct 16, 2023 Form 4 ↗
Wittouck Amaury10% owner Purchase +2.2M $6.85 $15.0M11.2Mdirect Oct 12, 2023Oct 16, 2023 Form 4 ↗
Qatanani MoSVP AND HEAD OF RESEARCH Sale −1,945 $6.34 $12K97.0Kdirect Sep 18, 2023Sep 20, 2023 Form 4 ↗
Parlavecchio CarynCHRO Sale −1,353 $6.83 $9K117.2Kdirect Aug 16, 2023Aug 18, 2023 Form 4 ↗
Artal International Management S.A.10% owner Purchase +31.6K $6.43 $203K9.1Mdirect Apr 28, 2023May 2, 2023 Form 4 ↗
Artal Group S.A.10% owner Sale −1,094 $9.48 $10K9.0Mdirect Jan 9, 2023Jan 11, 2023 Form 4 ↗
Artal Group S.A.10% owner Purchase +48.8K $9.33 $455K9.0Mdirect Jan 5, 2023Jan 9, 2023 Form 4 ↗
Stichting Administratiekantoor Westend10% owner Purchase +130.3K $8.04 $1.0M9.0Mdirect Oct 25, 2022Oct 27, 2022 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Purchase +66.0K $7.89 $521K8.9Mdirect Oct 4, 2022Oct 7, 2022 Form 4 ↗
Invus Public Equities Advisors, LLC10% owner Purchase +34.0K $7.03 $239K8.8Mdirect Oct 3, 2022Oct 7, 2022 Form 4 ↗
Nashat AmirDirector Purchase +66.1K $4.90 $324K206.9Kindirect Jun 22, 2022Jun 24, 2022 Form 4 ↗
Nashat AmirDirector Purchase +1.1M $4.90 $5.5M3.5Mindirect Jun 22, 2022Jun 24, 2022 Form 4 ↗
Myles Edward HChief Financial Officer Sale −4,879 $35.05 $171K24.1Kdirect Nov 15, 2021Nov 15, 2021 Form 4 ↗
Myles Edward HChief Financial Officer Sale −49.8K $35.12 $1.8M24.1Kdirect Nov 12, 2021Nov 15, 2021 Form 4 ↗
Myles Edward HChief Financial Officer Sale −23.6K $35.20 $830K24.1Kdirect Nov 11, 2021Nov 15, 2021 Form 4 ↗
FLIER JEFFREY S.Director Sale −6,000 $30.89 $185K22.3Kindirect Oct 1, 2021Oct 5, 2021 Form 4 ↗
FLIER JEFFREY S.Director Sale −500 $34.09 $17K9,013direct Sep 20, 2021Sep 21, 2021 Form 4 ↗
FLIER JEFFREY S.Director Sale −3,037 $31.48 $96K28.3Kindirect Jul 26, 2021Jul 28, 2021 Form 4 ↗
FLIER JEFFREY S.Director Sale −2,963 $31.84 $94K31.3Kindirect Jul 26, 2021Jul 28, 2021 Form 4 ↗
Gilman MichaelDirector Sale −4,696 $65.59 $308K37.5Kdirect Mar 15, 2021Mar 17, 2021 Form 4 ↗
Gilman MichaelDirector Sale −1,804 $65.06 $117K42.2Kdirect Feb 8, 2021Feb 11, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale Amended −1,561 $57.79 $90K32.7Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale Amended −12.1K $56.72 $689K34.3Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale Amended −5,400 $55.87 $302K46.4Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −1,561 $57.79 $90K26.9Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −12.1K $56.72 $689K28.4Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −5,400 $55.87 $302K40.6Kdirect Jan 27, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale Amended −1,064 $61.52 $65K51.8Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale Amended −2,543 $60.65 $154K52.9Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Gilman MichaelDirector Sale −1,518 $59.90 $91K44.0Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Gilman MichaelDirector Sale −1,500 $59.02 $89K45.5Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Gilman MichaelDirector Sale −483 $57.99 $28K47.0Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −1,064 $61.52 $65K46.0Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −8,417 $60.65 $510K47.0Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −9,249 $59.69 $552K55.4Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −13.4K $58.79 $786K64.7Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Carven Gregory JohnHead of Research Sale −4,676 $57.91 $271K78.1Kdirect Jan 26, 2021Jan 28, 2021 Form 4 ↗
Polaris Venture Partners VI, L.P.10% owner Purchase +7,887 n/c —156.4Kindirect May 29, 2018May 31, 2018 Form 4 ↗
Polaris Venture Partners VI, L.P.10% owner Purchase +135.0K n/c —2.7Mindirect May 29, 2018May 31, 2018 Form 4 ↗
Nashat AmirDirector · 10% owner Purchase +7,887 n/c —156.4Kindirect May 29, 2018May 31, 2018 Form 4 ↗
Nashat AmirDirector · 10% owner Purchase +135.0K n/c —2.7Mindirect May 29, 2018May 31, 2018 Form 4 ↗
Artal Group S.A.10% owner Purchase +450.0K n/c —450.0Kindirect May 29, 2018May 31, 2018 Form 4 ↗
SPRINGER TIMOTHY ADirector · 10% owner Purchase +71.4K n/c —3.3Mdirect May 29, 2018May 31, 2018 Form 4 ↗

Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Sep 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →